Jorn Aldag is the founder of Hookipa Pharma. Hookipa Pharma has raised $30M in total funding. Latest round: Series B. Based in Vienna, Austria.
Jörn Aldag was appointed CEO of Hookipa Biotech, a company specializing in immunotherapies and vaccines, in June 2016. The company had secured €27 million in Series A and Series B financing rounds, along with an additional €11 million in non-dilutive funds. Aldag brought extensive leadership experience from other immunotherapy companies, including uniQure, Molecular Partners, and Unum Therapeutics, and has a track record of building companies and taking them to public markets.
Full founder directory · Investor directory · Company funding database · Fundraising library